{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:29:03Z","timestamp":1780615743926,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T00:00:00Z","timestamp":1369180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00192-013-2121-z","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T16:23:45Z","timestamp":1369153425000},"page":"2081-2085","source":"Crossref","is-referenced-by-count":20,"title":["Differences in sacral neuromodulation device infection rates based on preoperative antibiotic selection"],"prefix":"10.1007","volume":"24","author":[{"given":"Allen M.","family":"Haraway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Quentin","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humphrey O.","family":"Atiemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne P.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,22]]},"reference":[{"issue":"1","key":"2121_CR1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0094-0143(21)00848-X","volume":"19","author":"SW Siegel","year":"1992","unstructured":"Siegel SW (1992) Management of voiding dysfunction with an implantable neuroprosthesis. Urol Clin N Am 19(1):163\u2013170","journal-title":"Urol Clin N Am"},{"issue":"1","key":"2121_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000474266","volume":"24","author":"HE Dijkema","year":"1993","unstructured":"Dijkema HE, Weil EH, Mijs PT et al (1993) Neuromodulation of sacral nerves for incontinence and voiding dysfunctions. Clinical results and complications. Eur Urol 24(1):72\u201376","journal-title":"Eur Urol"},{"issue":"2 Pt 1","key":"2121_CR3","first-page":"504","volume":"154","author":"JL Bosch","year":"1995","unstructured":"Bosch JL, Groen J (1995) Sacral (S3) segmental nerve stimulation as a treatment for urge incontinence in patients with detrusor instability: results of chronic electrical stimulation using an implantable neural prosthesis. J Urol 154(2 Pt 1):504\u2013507","journal-title":"J Urol"},{"issue":"5","key":"2121_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s003450050074","volume":"16","author":"EH Weil","year":"1998","unstructured":"Weil EH, Ruiz Cerda JL, Eerdmans PH et al (1998) Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. World J Urol 16(5):313\u2013321","journal-title":"World J Urol"},{"key":"2121_CR5","unstructured":"FDA. Medical devices: device approvals and clearances. (2011) Medtronic\u00ae InterStim\u00ae Therapy System\u2013P080025. www.fda.gov\/MedicalDevices\/ProductsandMedicalProcedures\/DeviceApprovalsandClearances\/Recently-ApprovedDevices\/ucm249208.htm . Accessed 10 May 2011"},{"key":"2121_CR6","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/nau.20786","volume":"29","author":"NY Siddiqui","year":"2010","unstructured":"Siddiqui NY, Wu JM, Amundsen CL (2010) Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourol Urodyn 29:S18\u2013S23","journal-title":"Neurourol Urodyn"},{"issue":"20","key":"2121_CR7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1185\/030079908X253555","volume":"24","author":"TM Kessler","year":"2008","unstructured":"Kessler TM, Burkhard FC, Madersbacher H et al (2008) Safety of prolonged sacral neuromodulation tined lead testing. Curr Med Res Opin 24(20):343\u2013347","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"2121_CR8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1464-410X.2009.08501.x","volume":"104","author":"M Huwyler","year":"2009","unstructured":"Huwyler M, Gustav K, Burkhard F et al (2009) Microbiological tined-lead examination: does prolonged sacral neuromodulation testing induce infection? BJU Int 104(5):646\u2013650","journal-title":"BJU Int"},{"key":"2121_CR9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s11605-010-1177-z","volume":"14","author":"SD Wexner","year":"2010","unstructured":"Wexner SD, Hull T, Yair E et al (2010) Infection rates in a large investigational trial of sacral nerve stimulation for fecal incontinence. J Gastrointest Surg 14:1081\u20131089","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"2121_CR10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.urology.2007.01.099","volume":"69","author":"ML Guralnick","year":"2007","unstructured":"Guralnick ML, Benouni S, O\u2019Connor RC et al (2007) Characteristics of infections in patients undergoing staged implantation of sacral nerve stimulation. Urology 69(6):1073\u20131076","journal-title":"Urology"},{"key":"2121_CR11","unstructured":"American Urological Association (2008) Best practice policy statement on urologic surgery antimicrobial prophylaxis. http:\/\/www.auanet.org\/content\/media\/antimicroprop08.pdf . Accessed 20 March 2012"},{"issue":"2","key":"2121_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1525-1403.2010.00317.x","volume":"14","author":"J Rudiger","year":"2011","unstructured":"Rudiger J, Thomson S (2011) Infection rate of spinal cord stimulators after a screening trial period. A 53-month third party follow-up. Neuromodulation 14(2):136\u2013141","journal-title":"Neuromodulation"},{"issue":"2","key":"2121_CR13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1227\/01.neu.0000316002.03765.33","volume":"62","author":"KA Sillay","year":"2008","unstructured":"Sillay KA, Larson PS, Starr PA (2008) Deep brain stimulator hardware-related infections: incidence and management in a large series. Neurosurgery 62(2):360\u2013366","journal-title":"Neurosurgery"},{"issue":"12","key":"2121_CR14","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00701-011-1130-2","volume":"153","author":"M Piacentino","year":"2011","unstructured":"Piacentino M, Pilleri M, Bartolomei L (2011) Hardware-related infections after deep brain stimulation surgery: review of incidence, severity and management in 212 single-center procedures in the first year after implantation. Acta Neurochir 153(12):2337\u20132341","journal-title":"Acta Neurochir"},{"issue":"5","key":"2121_CR15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/02688697.2011.566384","volume":"25","author":"R Bhatia","year":"2011","unstructured":"Bhatia R, Dalton A, Richards M, Hopkins C, Aziz T, Nandi D (2011) The incidence of deep brain stimulator hardware infection: the effect of change in antibiotic prophylaxis regimen and review of the literature. Br J Neurosurg 25(5):625\u2013631","journal-title":"Br J Neurosurg"},{"key":"2121_CR16","unstructured":"Interstim and Interstim II Implant Manual (2012) http:\/\/professional.medtronic.com\/wcm\/groups\/mdtcom_sg\/@mdt\/@neuro\/documents\/documents\/sns-is3058-23-impmanl.pdf . Accessed November 2012"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-013-2121-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-013-2121-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-013-2121-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T15:09:40Z","timestamp":1645110580000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-013-2121-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,22]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s00192-013-2121-z","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,22]]}}}